clinical trial · NCT06853184
Study Evaluating the Efficacy and Safety of Artesunate
CMV InfectionArtesunateGanciclovir (GCV)
brief summary
This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared to GCV or VGCV monotherapy and SOC treatment in SOT recipients with clinically significant CMV infection.
started
Aug 1, 2025
primary completion
May 31, 2028
completion
Jun 30, 2028
last updated
Oct 20, 2025
official title
Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol